Medco Health Solutions (MHS) Shareholder Lawsuit

Kyros & Pressly LLP Investigating Claims on Behalf of Investors Medco

Kyros & Pressly a Boston-based law firm has launched an investigation concerning potential legal claims against the Board of Directors of Medco Health Solutions (Medco) related to the merger of Medco merger with Express Scripts Inc.  The merger values Medco at approximately 29 billion dollars.

Medco is a pharmacy-benefit manager, which helps employers and health-insurance companies administer prescription-drug benefits, process claims and control drug costs by securing discounts from pharmaceutical companies. Analysts say these companies are expected to benefit from the health-care overhaul law, which will bring millions of Americans under insurance coverage. Medco, spun out of drug giant Merck & Co. in 2003, provides clinical research and pharmacy services aimed at improving care while reducing health-care costs for private and public employers, union and government agencies. The company took in $66 billion in 2010 net revenue.  Medco, which employs more than 24,000 people, is one of America's largest buyers of generic drugs.

Kyros & Pressly LLP is investigating the fairness of the proposed transaction to Medco shareholders, whether the shareholders are being underpaid for their stock, and whether Medco Board of Directors acted in the shareholders' best interests. In particular, given the critical role companies such as Medco will play under the new Health care laws, the Kyros & Pressly LLP is evaluating whether Medco’s Board of Directors considered all potential alternatives and obtained the best price for the shareholders.

If you are a shareholder of any amount of Medoc please call Attorney Bill Kyros or George Pressly at 1-800-934-2921 to discuss your rights.

Kyros & Pressly LLP is a Boston-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For info about our law firm please our Kyros Pressly LLP web site.